A Reliability and Validity Study: Urdu Version of Rivermead Extended Activities of Daily Life

June 15, 2022 updated by: Riphah International University

Analysis of Reliability and Validity of Urdu Version of Rivermead Extended Activities of Daily Life Among Pakistani Population

The goal of this study is to translate and culturally adapt Rivermead Extended Activities of Daily Life into the Urdu language and to evaluate its reliability and validity in the Pakistani neurological rehabilitation population. Also assess its correlation with Memory and Concentration Test, The Barthel Index, and The index of French activities.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

As per the preceding commendation, Rivermead Extended Activities of Daily Life will be deciphered into the Urdu dialect from its English adaptation and adjusted socially in Pakistan. Among the neurological rehabilitation population, Rivermead Extended Activities of Daily Life will be distributed in 100 patients enrolled by comfort inspecting strategy beneath the pre-defined incorporation and avoidance criteria after marking assent shapes. For testing inter-observer unwavering quality and intra-observer unwavering quality of Rivermead Extended Activities of Daily Life, Memory and Concentration Test, index of French activities, and Barthel Index surveys will be managed by spectator, on the same day, with a time interval of 2 hours between 1st and 2nd readings. As for the 3rd readings, it will be carried out after seven days by the first observer, for intra-observer appraisal. Statistical Package of Social Sciences computer program has been utilized for information passage and examination. Inner consistency will be analyzed with Cronbach alpha esteem. Test-retest unwavering quality will be surveyed by utilizing an intra-class relationship coefficient. The Rivermead Extended Activities of Daily Life will be assessed for content validity, construct validity, criterion validity, and responsiveness.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Faisalabad, Punjab, Pakistan, 38000
        • Recruiting
        • ripah international university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

We targeted the Pakistani stroke and head injury population received rehabilitation for neurological impairments in our study.

Description

Inclusion Criteria:

  • Patients from Rehabilitation centers mainly outpatients; with more or severe impairments due to neurological /neuro-muscular diseases.
  • Patient should be in a stable state unlikely to change over 2- weeks.
  • Patient should score 18/28 short orientation-memory-concentration test; indicating a reasonable cognitive and communicative ability.

Exclusion Criteria:

  • People not suffering from any neurological impairment.
  • Scorning less than 18/28 on short orientation-memory-concentration test.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Rivermead Extended Activities of Daily Life
Time Frame: 1st day
Rivermead Extended Activities of Daily Life having 10 things in it is in fact could be a complete independent community survival scale, covering all the fundamental independent living fashion needs. Restoration administrations are pointed at accomplishing social autonomy within the community, on the off chance that conceivable, and must utilize an fitting degree of Rivermead Extended Activities of Daily Life when they are assessed themselves.
1st day
Memory and Concentration Test
Time Frame: 1st day
The Brief Introduction Memory and Concentration Test is one of numerous tests of memory and concentration. It has the advantage of having decently culture-free substance. In expansion, it covers moderately restricted zones of cognition: is the individual arranged; can the individual center on a brief errand; and can the person learn and keep in mind a number of basic things.
1st day
Frenchay Activities Index
Time Frame: 1st day
The Frenchay Activities Index is a measure of instrumental activities of daily living for use with patients recovering from stroke.
1st day
Barthel Index
Time Frame: 1st day
The Barthel index is used to assess disability and to monitor changes in disability over time. The scoring method takes into account whether the person evaluated receives help while doing each task.
1st day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 30, 2021

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 10, 2022

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 12, 2022

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 15, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 15, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 21, 2022

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 21, 2022

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 15, 2022

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • REC-FSD-00263

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings